Dr Reddy#39;s launches generic version of Sapropterin Dihydrochloride tablets in US market
This product demonstrates that the company is actively expanding the breadth of its portfolio with a treatment for a rare disease, he added.
from Moneycontrol Business News https://ift.tt/2GyssYC
from Moneycontrol Business News https://ift.tt/2GyssYC
No comments: